A citation-based method for searching scientific literature

Mahtab Farzin, Christopher W Toon, Adele Clarkson, Loretta Sioson, Nicole Watson, Juliana Andrici, Anthony J Gill. Pathology 2015
Times Cited: 77







List of co-cited articles
453 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Germline BAP1 mutations predispose to malignant mesothelioma.
Joseph R Testa, Mitchell Cheung, Jianming Pei, Jennifer E Below, Yinfei Tan, Eleonora Sementino, Nancy J Cox, A Umran Dogan, Harvey I Pass, Sandra Trusa,[...]. Nat Genet 2011
634
54

High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma.
Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh Luk, Francine Baumann, Yu-An Zhang, Adi Gazdar, Shreya Kanodia,[...]. J Thorac Oncol 2015
189
46

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.
Matthew Bott, Marie Brevet, Barry S Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard A Lake, Maureen F Zakowski, Boris Reva,[...]. Nat Genet 2011
461
42

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
Marta Cigognetti, Silvia Lonardi, Simona Fisogni, Piera Balzarini, Vilma Pellegrini, Andrea Tironi, Luisa Bercich, Mattia Bugatti, Giulio Rossi, Bruno Murer,[...]. Mod Pathol 2015
152
41

BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.
Brandon S Sheffield, Harry C Hwang, Anna F Lee, Kim Thompson, Stephanie Rodriguez, Christopher H Tse, Allen M Gown, Andrew Churg. Am J Surg Pathol 2015
112
36

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
Stephanie M McGregor, Ryan Dunning, Elizabeth Hyjek, Wickii Vigneswaran, Aliya N Husain, Thomas Krausz. Hum Pathol 2015
78
33

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
Francine Baumann, Erin Flores, Andrea Napolitano, Shreya Kanodia, Emanuela Taioli, Harvey Pass, Haining Yang, Michele Carbone. Carcinogenesis 2015
140
32

Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology.
Juliana Andrici, Amy Sheen, Loretta Sioson, Kathryn Wardell, Adele Clarkson, Nicole Watson, Mahsa S Ahadi, Mahtab Farzin, Christopher W Toon, Anthony J Gill. Mod Pathol 2015
66
37

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma.
Yoshie Yoshikawa, Ayuko Sato, Tohru Tsujimura, Mitsuru Emi, Tomonori Morinaga, Kazuya Fukuoka, Shusai Yamada, Aki Murakami, Nobuyuki Kondo, Seiji Matsumoto,[...]. Cancer Sci 2012
124
31

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.
Karen H Ventii, Narra S Devi, Kenneth L Friedrich, Tatiana A Chernova, Mourad Tighiouart, Erwin G Van Meir, Keith D Wilkinson. Cancer Res 2008
234
31

BAP1 and cancer.
Michele Carbone, Haining Yang, Harvey I Pass, Thomas Krausz, Joseph R Testa, Giovanni Gaudino. Nat Rev Cancer 2013
388
29

BAP1 protein is a progression factor in malignant pleural mesothelioma.
Lisa Arzt, Franz Quehenberger, Iris Halbwedl, Thomas Mairinger, Helmut H Popper. Pathol Oncol Res 2014
54
40

Tumours associated with BAP1 mutations.
Rajmohan Murali, Thomas Wiesner, Richard A Scolyer. Pathology 2013
177
28

BAP1 loss defines a new class of renal cell carcinoma.
Samuel Peña-Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao, Nan Leng, Andrea Pavía-Jiménez, Shanshan Wang, Toshinari Yamasaki, Leah Zhrebker, Sharanya Sivanand, Patrick Spence,[...]. Nat Genet 2012
604
22

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
467
22

Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.
Guangwu Guo, Juliann Chmielecki, Chandra Goparaju, Adriana Heguy, Igor Dolgalev, Michele Carbone, Sara Seepo, Matthew Meyerson, Harvey I Pass. Cancer Res 2015
196
22

Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
Harry C Hwang, Brandon S Sheffield, Stephanie Rodriguez, Kim Thompson, Christopher H Tse, Allen M Gown, Andrew Churg. Am J Surg Pathol 2016
99
20

Germline BAP1 mutations predispose to renal cell carcinomas.
Tatiana Popova, Lucie Hebert, Virginie Jacquemin, Sophie Gad, Virginie Caux-Moncoutier, Catherine Dubois-d'Enghien, Bénédicte Richaudeau, Xavier Renaudin, Jason Sellers, André Nicolas,[...]. Am J Hum Genet 2013
181
19

Frequent mutation of BAP1 in metastasizing uveal melanomas.
J William Harbour, Michael D Onken, Elisha D O Roberson, Shenghui Duan, Li Cao, Lori A Worley, M Laurin Council, Katie A Matatall, Cynthia Helms, Anne M Bowcock. Science 2010
894
19

Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair.
Helen Yu, Helen Pak, Ian Hammond-Martel, Mehdi Ghram, Amélie Rodrigue, Salima Daou, Haithem Barbour, Luc Corbeil, Josée Hébert, Elliot Drobetsky,[...]. Proc Natl Acad Sci U S A 2014
217
19

New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?
Andrew Churg, Brandon S Sheffield, Francoise Galateau-Salle. Arch Pathol Lab Med 2016
96
19

BRCA1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: A Large Retrospective Study.
Luisella Righi, Eleonora Duregon, Simona Vatrano, Stefania Izzo, Jessica Giorcelli, Milena Rondón-Lagos, Valeria Ascoli, Enrico Ruffini, Laura Ventura, Marco Volante,[...]. J Thorac Oncol 2016
51
29

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Mohamed H Abdel-Rahman, Robert Pilarski, Colleen M Cebulla, James B Massengill, Benjamin N Christopher, Getachew Boru, Peter Hovland, Frederick H Davidorf. J Med Genet 2011
302
18

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.
Simion Chiosea, Alyssa Krasinskas, Philip T Cagle, Kisha A Mitchell, Dani S Zander, Sanja Dacic. Mod Pathol 2008
139
18

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
D E Jensen, M Proctor, S T Marquis, H P Gardner, S I Ha, L A Chodosh, A M Ishov, N Tommerup, H Vissing, Y Sekido,[...]. Oncogene 1998
512
18

Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
K Rai, R Pilarski, C M Cebulla, M H Abdel-Rahman. Clin Genet 2016
120
18

BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas.
Harry C Hwang, Shawna Pyott, Stephanie Rodriguez, Ashlie Cindric, April Carr, Carmen Michelsen, Kim Thompson, Christopher H Tse, Allen M Gown, Andrew Churg. Am J Surg Pathol 2016
60
21

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.
Raphael Bueno, Eric W Stawiski, Leonard D Goldstein, Steffen Durinck, Assunta De Rienzo, Zora Modrusan, Florian Gnad, Thong T Nguyen, Bijay S Jaiswal, Lucian R Chirieac,[...]. Nat Genet 2016
455
16

BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation.
Angela Bononi, Carlotta Giorgi, Simone Patergnani, David Larson, Kaitlyn Verbruggen, Mika Tanji, Laura Pellegrini, Valentina Signorato, Federica Olivetto, Sandra Pastorino,[...]. Nature 2017
206
16

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.
Yuchen Jiao, Timothy M Pawlik, Robert A Anders, Florin M Selaru, Mirte M Streppel, Donald J Lucas, Noushin Niknafs, Violeta Beleva Guthrie, Anirban Maitra, Pedram Argani,[...]. Nat Genet 2013
447
15

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
Aliya N Husain, Thomas Colby, Nelson Ordonez, Thomas Krausz, Richard Attanoos, Mary Beth Beasley, Alain C Borczuk, Kelly Butnor, Philip T Cagle, Lucian R Chirieac,[...]. Arch Pathol Lab Med 2013
299
15

Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
Marta Betti, Elisabetta Casalone, Daniela Ferrante, Antonio Romanelli, Federica Grosso, Simonetta Guarrera, Luisella Righi, Simona Vatrano, Giuseppe Pelosi, Roberta Libener,[...]. Genes Chromosomes Cancer 2015
43
27

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.
Marjorie G Zauderer, Matthew Bott, Robert McMillan, Camelia S Sima, Valerie Rusch, Lee M Krug, Marc Ladanyi. J Thorac Oncol 2013
55
21

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
Aliya Noor Husain, Thomas V Colby, Nelson G Ordóñez, Timothy Craig Allen, Richard Luther Attanoos, Mary Beth Beasley, Kelly Jo Butnor, Lucian R Chirieac, Andrew M Churg, Sanja Dacic,[...]. Arch Pathol Lab Med 2018
265
15


Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.
Anna E Koopmans, Robert M Verdijk, Rutger W W Brouwer, Thierry P P van den Bosch, Mike M P van den Berg, Jolanda Vaarwater, Christel E M Kockx, Dion Paridaens, Nicole C Naus, Mark Nellist,[...]. Mod Pathol 2014
131
14

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
Nicholas J Vogelzang, James J Rusthoven, James Symanowski, Claude Denham, E Kaukel, Pierre Ruffie, Ulrich Gatzemeier, Michael Boyer, Salih Emri, Christian Manegold,[...]. J Clin Oncol 2003
14

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
Aatur D Singhi, Alyssa M Krasinskas, Haroon A Choudry, David L Bartlett, James F Pingpank, Herbert J Zeh, Alyssa Luvison, Kimberly Fuhrer, Nathan Bahary, Raja R Seethala,[...]. Mod Pathol 2016
78
14

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
Michele Carbone, Laura Korb Ferris, Francine Baumann, Andrea Napolitano, Christopher A Lum, Erin G Flores, Giovanni Gaudino, Amy Powers, Peter Bryant-Greenwood, Thomas Krausz,[...]. J Transl Med 2012
193
12

Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Jinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, Jianming Pei, Jacqueline Talarchek, Eleonora Sementino, Yinfei Tan, Craig W Menges, Kathy Q Cai, Samuel Litwin,[...]. Cancer Res 2014
89
12

Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.
Juliana Andrici, Thomas R Parkhill, Jason Jung, Kathryn L Wardell, Brandon Verdonk, Arjun Singh, Loretta Sioson, Adele Clarkson, Nicole Watson, Amy Sheen,[...]. Pathology 2016
30
33

Gene of the month: BAP1.
Ami Wang, Anjali Papneja, Martin Hyrcza, Ayman Al-Habeeb, Danny Ghazarian. J Clin Pathol 2016
51
19

BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.
Stephanie M McGregor, James McElherne, Agata Minor, Jennifer Keller-Ramey, Ryan Dunning, Aliya N Husain, Wickii Vigneswaran, Carrie Fitzpatrick, Thomas Krausz. Hum Pathol 2017
26
38

Germline BAP1 mutations predispose also to multiple basal cell carcinomas.
A de la Fouchardière, O Cabaret, L Savin, P Combemale, H Schvartz, C Penet, V Bonadona, N Soufir, B Bressac-de Paillerets. Clin Genet 2015
68
13

The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.
Sara E Monaco, Yongli Shuai, Mona Bansal, Alyssa M Krasinskas, Sanja Dacic. Am J Clin Pathol 2011
82
11

Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.
Di Wu, Kenzo Hiroshima, Shinji Matsumoto, Kazuki Nabeshima, Toshikazu Yusa, Daisuke Ozaki, Michio Fujino, Hisami Yamakawa, Yukio Nakatani, Yuji Tada,[...]. Am J Clin Pathol 2013
69
13

FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma.
Catherine T-S Chung, Gilda Da Cunha Santos, David M Hwang, Olga Ludkovski, Melania Pintilie, Jeremy A Squire, Ming-Sound Tsao. J Clin Pathol 2010
66
13

Germline mutations in BAP1 impair its function in DNA double-strand break repair.
Ismail Hassan Ismail, Riley Davidson, Jean-Philippe Gagné, Zhi Zhong Xu, Guy G Poirier, Michael J Hendzel. Cancer Res 2014
125
11


Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma.
Juliana Andrici, Jason Jung, Amy Sheen, Lisa D'Urso, Loretta Sioson, Justine Pickett, Thomas R Parkhill, Brandon Verdonk, Kathryn L Wardell, Arjun Singh,[...]. Hum Pathol 2016
46
19


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.